Vaccine Packaging Market 2026, driven by expanding immunization programs and cold chain demands in Asia-Pacific and North America| Key Players:- SCHOTT AG, SGD S.A., Catalent, Inc

Leander Texas-
Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.

DataM Intelligence has released a new research report titled "Vaccine Packaging Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Vaccine Packaging Market.

Get a Free Sample Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/vaccine-packaging-market?prtk

The Vaccine Packaging Market is becoming increasingly important in 2026 due to the rising global focus on immunization programs, biologics, and pandemic preparedness. With the expansion of vaccine production and distribution, especially in emerging markets, there is a strong demand for advanced packaging solutions that ensure product safety, stability, and extended shelf life. Innovations such as temperature-controlled packaging, smart labeling, and sustainable materials are further driving the market's relevance.

Investors are attracted to this market because of its stable and growing demand, supported by government vaccination initiatives, increasing healthcare spending, and continuous R&D in vaccines. Additionally, the shift toward mRNA and biologic vaccines requires specialized packaging, creating high-value opportunities. The market also benefits from long-term contracts, regulatory support, and the critical role it plays in global healthcare infrastructure, making it a reliable and future-proof investment segment.

List of Key Players 2026:
Gerresheimer AG | West Pharmaceutical Services, Inc | Becton, Dickinson & Company | SCHOTT AG | SGD S.A. | Catalent, Inc | Stevanato Group | Nipro Corporation | Piramal Glass Private Limited | UDG Healthcare plc

Growth Forecast Projected 2026:

The Global Vaccine Packaging Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Key Developments 2025-2026:

United States
✅ December 2025: West Pharmaceutical Services, Inc. introduced next-gen ready-to-use sterile vial packaging with enhanced barrier coatings, improving vaccine shelf life and reducing contamination risks during cold-chain transport.
✅ October 2025: Becton, Dickinson and Company expanded its prefillable syringe packaging line with integrated safety shielding, supporting large-scale vaccine distribution programs and minimizing needlestick injuries.
✅ August 2025: Gerresheimer AG strengthened its U.S. operations by upgrading glass vial production facilities, focusing on high-quality borosilicate vials tailored for mRNA and biologic vaccines.

Japan
✅ November 2025: Nipro Corporation launched advanced cyclic olefin polymer (COP) vaccine vials in Japan, offering higher break resistance and compatibility with sensitive biologics.
✅ September 2025: SCHOTT AG expanded its vaccine packaging solutions in Japan with ultra-low particulate glass vials, supporting stringent quality requirements for injectable vaccines.
✅ July 2025: Stevanato Group introduced ready-to-use EZ-fill® syringe packaging in the Japanese market, enhancing sterility assurance and accelerating fill-finish processes for vaccine manufacturers.
How Our Market Research Process Works:

The global Vaccine Packaging Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Low-Power Wide-Area Network ecosystem.

Recent Mergers & Acquisitions (M & A):
✅ Gerresheimer AG strengthened its pharmaceutical and vaccine packaging capabilities in January 2025 by acquiring a controlling stake in a specialized glass and polymer solutions manufacturer. The move enhances its production capacity for high-value containment solutions such as vials and prefilled syringes, supporting growing global vaccine demand.
✅ Stevanato Group expanded its global footprint in December 2024-early 2025 through the acquisition of a specialty device assembly business. This acquisition supports integrated solutions for vaccine delivery systems, including prefilled syringes and drug containment platforms, improving end-to-end offerings for biopharma clients.
✅ SCHOTT AG enhanced its pharma packaging portfolio in November 2025 by acquiring niche pharmaceutical tubing assets. The transaction strengthens its borosilicate glass supply chain used in vaccine vials and cartridges, ensuring higher resilience and quality in sterile packaging production.
✅ West Pharmaceutical Services, Inc. expanded its injectable drug packaging segment in mid-2025 through the acquisition of a containment and delivery components manufacturer. This strategic move supports advanced elastomer and closure solutions widely used in vaccine packaging and biologics
✅ Catalent, Inc. advanced its biologics and vaccine fill-finish capabilities in early 2025 following acquisition activities focused on sterile manufacturing facilities. The deal strengthens its position in high-demand vaccine packaging services, particularly in aseptic filling and finishing operations.

Request Strategic Market Customization: https://www.datamintelligence.com/customize/vaccine-packaging-market?prtk

Major Focused Key Segmentations 2026:

-By Type: Vials and Ampoules Lead with High Safety Standards
Vials and ampoules dominate the vaccine packaging market with an estimated 48% share in 2025, driven by their critical role in maintaining sterility and stability of vaccines during storage and transportation. Their widespread adoption in immunization programs and biologics manufacturing strengthens their leadership.
Corrugated boxes account for 22%, supporting bulk transportation and ensuring structural protection across supply chains. Vaccine cool bags hold 18%, gaining traction due to cold chain requirements, while others contribute 12%, including specialized containers and advanced packaging formats.

-By Level: Primary Packaging Holds the Core Share
Primary packaging leads with approximately 55% market share, as it directly contains vaccines and ensures product integrity, sterility, and regulatory compliance. This segment includes vials, ampoules, and prefilled syringes, making it the most critical layer.
Secondary packaging accounts for 27%, focusing on labeling, branding, and additional protection, while tertiary packaging holds 18%, primarily used for bulk handling, storage, and logistics efficiency.

-By End-User: Biopharmaceutical Companies Drive Market Demand
Biopharmaceutical companies dominate the segment with around 46% share, supported by large-scale vaccine production, R&D investments, and global distribution networks. Their demand for high-quality, compliant packaging solutions fuels market growth.
Hospitals represent 24%, driven by increasing vaccination programs and storage needs. Medical laboratories hold 17%, supporting testing and controlled environments, while others account for 13%, including government agencies and research institutions involved in immunization initiatives.

Regional Growth Analysis for Market:

North America
North America dominates with a 34.2% revenue share in 2024, driven by robust vaccine production and cold chain infrastructure in the U.S. and Canada. The U.S. leads due to FDA regulations and demand for glass vials/prefilled syringes, with ongoing investments in smart packaging sustaining a 7.1% CAGR.​

Europe
Europe holds the largest share at 37.75% in 2024, supported by advanced healthcare systems and EMA standards. Germany excels in single-dose innovations and cold chain expansions, while high immunization rates fuel steady demand.
​
Asia Pacific
Asia Pacific grows fastest at 8.29% CAGR, propelled by vaccine hubs in India and China. India supplies 60-70% of WHO vaccines, boosting vials and trays amid population-driven needs; China adds scale via domestic manufacturing.
​
Latin America
Latin America sees steady expansion via public campaigns, with Brazil key for vials/syringes under ANVISA oversight. Investments in cold chains enhance distribution for domestic production.
​
Middle East & Africa
MEA grows via infrastructure builds, with GCC/South Africa focusing on temperature-stable formats for imports and emerging local immunization. Limited data shows reliance on insulated packaging for remote logistics.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=vaccine-packaging-market?prtk

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?prtk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.